ICMRA publishes best practices plan to fight antimicrobial resistance

Building on the antimicrobial resistance (AMR) joint statement published in 2019, the International Coalition of Medicines Regulatory Authorities (ICMRA) today issued a report that highlights successful regulatory and non-regulatory interventions used in different countries to address the growing public health problem of antimicrobial resistance (AMR).

ICMRA members include medicines regulators from across the world, including the European Medicines Agency and the US Food and Drug Administration.

According to the report, AMR threatens our ability to effectively treat infections because of an ever-increasing range of bacteria and other microorganisms that have adapted to become resistant to available treatments.